肺腺鳞癌研究进展  

Progression of diagnosis and treatment for adenosquamous lung carcinoma

作　　者：赵文君[1] 王旭[1] 马克威[1] 

机构地区：[1]吉林大学第一医院肿瘤中心,长春130021

出　　处：《中华肿瘤杂志》2017年第4期241-244,共4页Chinese Journal of Oncology

摘　　要：肺腺鳞癌是原发性肺癌中的少见类型，是由腺癌和鳞癌两种癌细胞成分组成，既具有肺腺癌和肺鳞癌的恶性生物学特性，也具有其特殊的临床特点，其恶性程度更高，预后较差。文章主要阐述肺腺鳞癌病理起源的研究历程、不同的诊断方法在肺腺鳞癌中的应用、各种治疗方式和预后情况，以期为制订肺腺鳞癌的临床诊治策略提供帮助。Adenosquamous lung carcinoma （ASC） is an uncommon entity of the primary lung cancer, which is mixed by adenocarcinoma and squamous carcinoma cells. ASC not only possesses the malignant biological characteristics of adenocarcinoma and squamous cell carcinoma, but also exhibits special clinical features, such as the higher malignant degree and poorer prognosis. This paper is aimed to elaborate the research process of the pathological origin of ASC, the application of different diagnostic methods in ASC, various therapeutic strategies and its associated prognosis so as to help to develop the clinical strategies of ASC.

关 键 词：肺腺鳞癌 病理学 临床 治疗 预后 

分 类 号：R734.2[医药卫生—肿瘤]